WHO ICTRP trial
clinical trial to study the effect of Unani formulation in patient with…
CTRI/2024/09/074424 · Clinical Trials Registry India (CTRI) · Not Recruiting
Key facts
| Trial ID | CTRI/2024/09/074424 |
|---|---|
| Public title | clinical trial to study the effect of Unani formulation in patient with Hyperlipidemia. |
| Scientific title | An Open Labelled Randomised Controlled clinical study to evaluate the safety and efficacy of Qurs-e-Luk in cases of Fart-e-Tadassum fid-dam (Hyperlipidemia) - NIL |
| Primary sponsor | PG Dept. of Moalijat |
| Registry | Clinical Trials Registry India (CTRI) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Phase 2 |
| Countries | India |
| Conditions | Health Condition 1: - Health Condition 2: E785- Hyperlipidemia, unspecified |
| Interventions | Intervention1: QURS-E-LUK: 2.5gm-BD,with water, after meal, with 4 follow ups at interval of 15 days. Control Intervention1: Tablet Atorvastatin-40 mg: OD-with water after meal, with 4 follow ups at interval of 15 days. |
| Registration date | Sep 26, 2024 |
| Target size | 40 |
| Secondary IDs | NIL |
| Registry page | ctri.nic.in |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: